ÃâÒßѧÊÔÌâ
p.g> +7 Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
sGtxqnX:J 1. Fas(CD95)/FasL
>W-xDzJry 2. common chain of cytokine receptor
E Zf|>^N 3 . TCR/CD3 complex
D3dh,&KO\ 4. negaive selection of thymocytes
>"<s7$g 5. artificial active immune
Tb?X KO, 6. anti-idiotypic
ineSo8| @ 7. IgSF
C za}cF 8. Integrin
]f&]E
~i 9. chemokine
x
z
F 10. B7/CD28
,pTZ/#vP# ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
Ji!i}UjD7! 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
]] 0 M 2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£
~b)X:ku 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£
u
uFQTx)) 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
LsIZeL^
n5A|Zjk; 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
=
E_i µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
(9aOET>GG Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
-nC&t~sD 1. B7/CD28
,{q#U3
2. Th1 subset
b~>@x{ 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
Y)]VlV!` 4. antibody affinity maturation
UQh.o 5. AP-1
[T7&)p 6. single chain variable fragment£¨ScFv£©
}15&<s 7. NK cell receptor
^vG<Ma.yk 8. Zinkernagel-Doherty phenomenon
R#~l[S8u^ 9. Ig fold
3
I%N4K4 10. CD40/CD40L
~YW;' ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
;rL1[qwk 1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£
!0zcS7&P 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
#M
w70@6 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
)^qXjF Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
{*hFG:u
1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
O
!dS;p-F 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
DcaKGjp 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£
RZpjr !R Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
y7#+VF`xf £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
;t9_*)[ Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
\oxf_4X 1.Co-stimulators (or co-stimulating molecules)
*!`&+w 2.NK-kB
Q-R?y+| x 3.Immunoglobulin superfamily
kP('X/ 4.antigen-presenting cell (APC)
b9?Vpu`? 5.death domain
='kCY}dkO 6.CCR and CXCR
n9&fH 7.Lectin (or mitogen)
c%b|+4
}x 8.Clusters of differentiation, CD)
|p*cI @ 9.B7 family
2,I]H'}^ 10.Cytotoxic T lymphocyte, CTL)
N&k\X]U 11.IL-15 and IL-15 receptor (IL-15R)
#H Jlm1d 12.MHC restriction
/\Xe'& 13.Affinity-chromatography
A\7sP = 14.Cyctosprin A, CsA
.@;5" 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
wS7Vo{#@\ ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
<Mo{o2F= 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
ZK2&l
8 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£
438r]f?0|{ 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£
.pl,ujv Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
{uZ|Oog(p ÃâÒßѧרҵ£º
x=W s)&H_Y 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
3ErV" R4"$ Ïû»¯ÄÚ¿Æ£º
3_
E}XQd 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
jL3
*m ѪҺ²¡Ñ§×¨Òµ£º
_E-{*,7bZS 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
9~K>c Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
1UrkDz?X (רҵ»ù´¡: ÃâÒßѧ)
Pq-@waH3 Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
4>Q] \\Lc 1. ADCC(antibody dependent cell-mediated cytotoxicity)
Bv*VNfUm 2. »·æß¾úËØ(cyclosporin)
0&&P+adk 3. KIR(killer cell inhibitory receptor)
}+[!h=Bx 4. HLDA(human leucocyte differentiation antigen)
=3V4HQi 5. Interleukin 18(IL-18)
FO]f 4@
6. ÕûºÏËØ(integrin)
Tn3C0 7. Fas/FasL
@JP6F[d 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
%A&g-4( 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
C<^
S$ 10. Th1/Th2
cZWW[i 11. »ùÒòÒßÃç(DNAÒßÃç)
B(-F|q\ 12. chemokines and chemokine receptor
K TE*Du 13. ÃâÒßÄÍÊÜ
@ <'a0)n> 14. ¹²´Ì¼¤·Ö×Ó
t#]VR7] 15. ËÀÍö½á¹¹Óò(death domain)
dW^#}kN7V ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
:}v:=c k 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
dsK^-e6:5 2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
cZt5;"xgr] £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
,zBc-Cm £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
9<Th: t|w £¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
% <%r £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
bG)6p05Oa 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
H[r6 4~Sth Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
I=K<%. ÎÊ´ðÌâ(ÿÌâ25·Ö)
j8t_-sU9 i 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£
kN vNV(4 2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿
ljh,%#95= 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£
J \I`# 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£